HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ximoprofen

Also Known As:

2-(4-(3-oximinocyclohexyl)phenyl)propionic acid; Benzeneacetic acid, 4-(3-(hydroxyimino)cyclohexyl)-alpha-methyl-

Networked: 1 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Carboxylic Acids: 973
  - Carbocyclic Acids
    - Phenylpropionates
      - ximoprofen: 1

Related Diseases

1.

Ankylosing Spondylitis

01/01/1994 - "Ximoprofen in ankylosing spondylitis. "
01/01/1994 - "Ximoprofen is a new propionic NSAID which has previously demonstrated its efficacy at a daily dose of 30 mg. The aim of the study was to evaluate the efficacy of different daily dosages of Ximoprofen in patients with active ankylosing spondylitis. "
01/01/1994 - "This study 1/confirms the efficacy of Ximoprofen at a 30 mg daily dosage, 2/shows the persistence of this efficacy at lower dosages, 3/suggests that ankylosing spondylitis is a sensitive and relevant human model to assess NSAIDs at an early stage of clinical evaluation."

Related Drugs and Biologics

1.	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)